论文部分内容阅读
1999年是我国中药市场较不景气的一年。回顾过去的一年,是销售滑坡,市价低迷,走势呆滞,药人愁眉不展的图画。总的趋势是俏少滞多,升少降多。1999年底与年初相比,从12大类550个品种品规来看: 一、根及根茎类172个品种中,上升品种15个,下降品种99个,58个品种持平。上升品种中上涨幅度不等,有高有低。红参类上升35％左右。黄连升幅为50～60％。在川贝下落的情况下,浙贝平步青云,上升53％,已突破20元大关。家种和野生天麻
In 1999, the Chinese medicine market was in a downturn. The review of the past year is a picture of the decline in sales, sluggish market prices, sluggish trends and drug-users scowling. The general trend is pretty little lag, more or less. At the end of 1999, compared with the beginning of the year, from the varieties and regulations of 550 varieties in 12 categories, the first and the 172 varieties of roots and rhizomes increased 15 varieties, 99 varieties decreased, and 58 varieties were flat. Rose varieties rose in range, high and low. Red ginseng rose by 35%. Coptis an increase of 50 to 60%. In the case of the fall of Chuanbei, Zhejiang Beppan albatrosses, up 53%, has exceeded 20 yuan mark. Home-grown and wild gastrodia